Ptps-based vaccines against cancer
A technology of PTP and vaccine, applied in the field of prior translation product, immune response, preferably immune response against tumor antigen, vaccine composition, composition containing said PTP
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0099] Example 1 - Combination of advanced translation products (PTPs) and exosomes: a novel cancer vaccine.
[0100] Materials and Methods
[0101] cell culture
[0102] at 37°C and 5% CO 2 Under standard conditions, the MCA 205 mouse sarcoma cell line was grown in RPMI 1640 medium (Life Technologies) in the presence of 1% glutamine, 1% pyruvate, 1% non-essential amino acids and 10% FBS (Life Technologies) under cultivation. at 37°C and 5% CO 2 B16F10 (syngeneic cells from C57BL / 6J mice) were cultured in DMEM containing 10% FCS, 2 mM L-glutamine and 100 IU / ml penicillin / streptomycin.
[0103] MCA 205 and B16F10 cells were transfected with the YFP-globin-intron-SL8-his plasmid using JetPrime according to the manufacturer's protocol for PTP purification (Ozyme). For tumor rejection experiments, stable MCA 205-Ova and stable B16F10-Ova cells were prepared. Stable MCA 205-Ova was grown in RPMI 1640 under standard conditions. Stable B16F10-Ova cells stably expressing oval...
Embodiment 2
[0137] Example 2 - Vaccine against melanoma
[0138] PTP-based vaccines against melanoma:
[0139] The inventors showed in Example 1 that PTP purified from sarcoma cell lines such as MCA205 can be used as a vaccine in mice to elicit specific anti-tumor T cell responses in a prophylactic manner. To expand the inventors' view that PTPs are useful as vaccines against cancer, they investigated other types of cancer. For this purpose, the inventors purified PTPs from melanoma cell lines such as the murine B16F10 cell line. Next, different groups of 6 mice were vaccinated with different concentrations of PTP, with the adjuvant itself (negative control) or with the SL8 epitope emulsified in the same adjuvant (positive control). These PTPs were purified from a mouse B16F10 tumor cell line previously transfected with our globin-intron-SL8-His construct. After 2 weeks, 50.10 4 The cells were injected subcutaneously into the right flank of mice, and the transfected B16F10 tumor cell ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com